Structural Characterization of a Minimal Antibody against Human APOBEC3B

Viruses. 2021 Apr 12;13(4):663. doi: 10.3390/v13040663.

Abstract

APOBEC3B (A3B) is one of seven human APOBEC3 DNA cytosine deaminases that restrict viral infections as part of the overall innate immune response, but it also plays a major role in tumor evolution by mutating genomic DNA. Given the importance of A3B as a restriction factor of viral infections and as a driver of multiple human cancers, selective antibodies against A3B are highly desirable for its specific detection in various research and possibly diagnostic applications. Here, we describe a high-affinity minimal antibody, designated 5G7, obtained via a phage display screening against the C-terminal catalytic domain (ctd) of A3B. 5G7 also binds APOBEC3A that is highly homologous to A3Bctd but does not bind the catalytic domain of APOBEC3G, another Z1-type deaminase domain. The crystal structure of 5G7 shows a canonical arrangement of the heavy and light chain variable domains, with their complementarity-determining region (CDR) loops lining an antigen-binding cleft that accommodates a pair of α-helices. To understand the mechanism of A3Bctd recognition by 5G7, we used the crystal structures of A3Bctd and 5G7 as templates and computationally predicted the A3B-5G7 complex structure. Stable binding poses obtained by the simulation were further tested by site-directed mutagenesis and in vitro binding analyses. These studies mapped the epitope for 5G7 to a portion of C-terminal α6 helix of A3Bctd, with Arg374 playing an essential role. The same region of A3Bctd was used previously as a peptide antigen for generating a rabbit monoclonal antibody (mAb 5210-87-13), suggesting that this region is particularly immunogenic and that these antibodies from very different origins may share similar binding modes. Our studies provide a platform for the development of selective antibodies against A3B and other APOBEC3 family enzymes.

Keywords: APOBEC3B; DNA cytosine deaminase; antiviral innate immunity; cancer mutagenesis; crystal structure; molecular dynamics simulation; monoclonal antibody; protein-protein docking; scFv; tumor evolution.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Antibodies, Monoclonal / chemistry*
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / metabolism*
  • Binding Sites, Antibody
  • Crystallization
  • Cytidine Deaminase / immunology*
  • Cytidine Deaminase / metabolism*
  • HEK293 Cells
  • Humans
  • Immunity, Innate
  • Minor Histocompatibility Antigens / immunology*
  • Minor Histocompatibility Antigens / metabolism*
  • Molecular Dynamics Simulation
  • Protein Binding
  • Single-Chain Antibodies / chemistry*
  • Single-Chain Antibodies / isolation & purification*
  • Single-Chain Antibodies / metabolism

Substances

  • Antibodies, Monoclonal
  • Minor Histocompatibility Antigens
  • Single-Chain Antibodies
  • APOBEC3B protein, human
  • Cytidine Deaminase